Registered entities
CEPTARIS THERAPEUTICS
Reg. No. 20555180United States
Yaupon Therapeutics Inc
Reg. No. 1175706United States
Innovation
4 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 414 times.
| Year | Filings |
|---|---|
| 2012 | 1 |
| 2013 | 4 |
| 2016 | 1 |
Investor mix
15 investors on record; lead investors include BioAdvance, Osage Venture Partners, Palo Alto Investors, Burrill and Company; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 53% |
| Private equity | 3 | 20% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 3 | 20% |